Screening – 40th Anniversary BLADE RUNNER: FINAL CUT + Q&A (Los Angeles)
VES Members and Up to two (2) Guests are Invited to a Screening of Warner Bros. Pictures’ BLADE RUNNER: FINAL CUT followed by a Q&A with the filmmakers. Panelists will include Academy and BAFTA nominated Special Photographic Effects Supervisor David Dryer, Academy and BAFTA Award-winning Action Prop Supervisor Michael L. Fink, VES, Technical Achievement Academy Award-winning Computer Engineer at Entertainment Effects Group (EEG) Richard Hollander, VES and Academy and BAFTA Award-winning Chief Model Maker at Entertainment Effects Group (EEG) Mark Stetson, VES, moderated by VES Fellow and former VES Board member Van Ling, VES.
Sony Pictures Imageworks guidelines require that all VES members must show photo ID & proof of vaccination against COVID-19 for admission.
Please RSVP below (VES members must login to sign up.)
Friday, August 5, 2022 at 7:00PM (RSVPs close on Friday at 10:00AM)
The Ray Harryhausen Theater on the Sony Pictures Imageworks Lot
9050 W. Washington Blvd., Culver City, CA 90232
(Complimentary parking is available in the underground lot on Washington.)
***VES Members: Please enter your first and last name in the “Attendee 1″ fields***
In an effort to prevent the spread of COVID-19, we ask that you or your guests do not attend VES events if you are experiencing any symptoms or if you have been exposed to the virus.
Screenings are overbooked to compensate for no-shows. Seating is limited and will be available on a first come, first served basis. An RSVP does not guarantee seating.
By signing up for this on-site, in-person screening/event sponsored by VES (Visual Effects Society), you willingly accept any potential inherent risks associated with COVID-19. VES cannot be held liable from any consequences that may transpire from said risk. Therefore, signing up for this screening/event infers implied consent of yourself and your party and hereby indemnifies and holds harmless VES, its directors, its employees and any other affiliated persons from any adverse medical or financial impact that may result from our participation.